Prognostic Factors Influencing Infectious Complications after Cytoreductive Surgery and HIPEC: Results from a Tertiary Referral Center

Table 4

Correlation between risk factors and infectious complications (univariate analysis).

Variables	Patients () (%)	Infectious complication () (%)
Age (years)
<61	82 (41)	19 (45)	0.06
>61	118 (59)	23 (55)
ASA score
<3	184 (92)	12 (28)	0.018
>3	16 (8)	30 (72)
SGA score
A	102 (51)	11 (26)	0.016
B/C	98 (49)	31 (74)
P. status (ECOG)
<2	107 (53)	15 (36)	0.03
>2	93 (47)	27 (64)
Cytoreduction
Primary	124 (62)	20 (48)	0.1
Secondary	76 (38)	22 (52)
PCI score
<15	62 (31)	16 (38)	0.05
>15	138 (69)	26 (62)
Ascites
Yes	92 (46)	23 (55)	0.06
No	108 (54)	19 (45)
Prev. chemotherapy
Yes	104 (52)	24 (57)	0.07
No	96 (48)	18 (43)
Intestinal obstruction
Yes	42 (21)	20 (48)	0.1
No	158 (79)	22 (52)
Colorectal resections
Yes	138 (69)	28 (67)	0.024
No	62 (31)	14 (33)
Length of surgical procedure (min)
	<423	159 (79.5)	17 (40)	0.059
>423	41 (20.5)	25 (60)
Number of surgical procedures
	<4	18 (9)	18 (43)	0.07
>4	182 (91)	24 (57)
Blood loss (ml)
<1400	93 (46.5)	13 (31)	0.04
>1400	107 (53.5)	29 (69)
ICU stay (hours)
<31	78 (39)	17 (40)	0.059
>31	122 (61)	25 (60)
HIPEC drugs
Cisplatin	132 (66)	20 (48)	0.1
Oxaliplatin	68 (34)	22 (52)
Post-op serum albumin (g/dl)
	<2	54 (27)	29 (69)	0.03
>2	146 (73)	13 (31)

Significant.